[Federal Register Volume 89, Number 141 (Tuesday, July 23, 2024)]
[Notices]
[Page 59742]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-16096]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2023-N-0795]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Survey on Quantitative Claims in 
Direct-to-Consumer Prescription Drug Advertising

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing 
that a collection of information entitled ``Electronic Records: 
Electronic Signatures'' has been approved by the Office of Management 
and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA).

FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-8867, 
[email protected].

SUPPLEMENTARY INFORMATION: On December 21, 2023, the Agency submitted a 
proposed collection of information entitled ``Survey on Quantitative 
Claims in Direct-to-Consumer Prescription Drug Advertising'' to OMB for 
review and clearance under 44 U.S.C. 3507. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number. 
OMB has now approved the information collection and has assigned OMB 
control number 0910-0929. The approval expires on June 30, 2027. A copy 
of the supporting statement for this information collection is 
available on the internet at https://www.reginfo.gov/public/do/PRAMain.

    Dated: July 17, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-16096 Filed 7-22-24; 8:45 am]
BILLING CODE 4164-01-P